Home » Topics » BioWorld Science

BioWorld Science
RSS

Ifenprodil will not advance into phase III trial for COVID-19

July 7, 2021

Eli Lilly and Company synthesizes GTPase KRAS mutant inhibitors

July 7, 2021

Kymera Therapeutics patents new PROTACs

July 7, 2021

Shionogi discloses new HDAC2 inhibitors

July 7, 2021

Vanderbilt University patents muscarinic M4 receptor antagonists

July 7, 2021

FDA clears IND for AGEN-1777

July 7, 2021

Positive phase I data for UBX-1325 in patients with advanced vascular eye disease

July 7, 2021

First patient dosed in phase IIb study of Lomecel-B in hypoplastic left heart syndrome

July 7, 2021

Positive interim data from phase Ib study of ARO-HIF2 in clear cell renal cell carcinoma

July 7, 2021

New beta-amyloid PET imaging agent [18F]Flotaza shows promise in Alzheimer's disease brain

July 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...